Polyrizon: Funding, Investors & Team (Sep 2026)
Polyrizon is a biotechnology company that develops intranasal medical products. It focuses on hydrogel-based nasal spray technologies that form protective barriers in the nasal cavity and enable intranasal delivery of active pharmaceutical ingredients. Its product development includes allergy, viral, and therapeutic delivery applications based on proprietary platforms.
Polyrizon has raised $3.5M across 1 funding round on record, the most recent an undisclosed round of $3.5M announced in Apr 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Polyrizon Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Polyrizon Funding Rounds
Polyrizon Founders and Leadership Team
No contact details are on record for this team yet.
Polyrizon Funding Compared to Other Biotechnology Startups
Polyrizon's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Polyrizon in Biotechnology and Ra'anana
Companies Similar to Polyrizon
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Polyrizon Funding FAQs
What does Polyrizon do?
Polyrizon is a biotechnology company that develops intranasal medical products. It focuses on hydrogel-based nasal spray technologies that form protective barriers in the nasal cavity and enable intranasal delivery of active pharmaceutical ingredients. Its product development includes allergy, viral, and therapeutic delivery applications based on proprietary platforms.
How much funding has Polyrizon raised?
Polyrizon has raised $3.5M across 1 round on record. The most recent is an undisclosed round of $3.5M announced in Apr 2026.
When did Polyrizon last raise funding?
Polyrizon's most recent funding round on record is an undisclosed round of $3.5M, announced in Apr 2026.
Who founded Polyrizon?
FundedIQ lists Tomer Izraeli (Founder) at Polyrizon.
Where is Polyrizon headquartered?
Polyrizon is based in Ra'anana, HaMerkaz, Israel.
How many employees does Polyrizon have?
Polyrizon is in the 1-10 employee band.
How does Polyrizon's funding compare to other Biotechnology startups?
Polyrizon's latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Polyrizon Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Polyrizon is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.